Clinical Trials
5 trialsNCT07110103 2026-02-27
JACKPOT38
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT06820762 2025-02-11
Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study
The Second Affiliated Hospital of Dalian Medical University
Phase 2 Not yet recruiting
NCT06475209 2024-06-26
Adebrelimab + Apatinib in SCLC Maintenance Therapy
Tang-Du Hospital
Phase 2 Recruiting
NCT03428607 2021-02-18
Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]
Samsung Medical Center
Phase 2 Completed
NCT04684017 2020-12-24
Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer
Shanghai Chest Hospital
Phase 2 Unknown